NeuroOne Medical Tech Q4 Sales $742.00K Miss $800.00K Estimate
Portfolio Pulse from Happy Mohamed
NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) reported Q4 sales of $742.00K, missing the consensus estimate of $800.00K by 7.25%. However, this represents a significant increase of 978.68% over the sales of $68.79K in the same period last year.
December 14, 2023 | 9:18 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
NeuroOne Medical Technologies Corporation's Q4 sales of $742.00K missed the estimated $800.00K by 7.25%, but showed a substantial year-over-year growth of 978.68%.
Missing the sales estimate is likely to have a negative impact on investor sentiment in the short term, despite the impressive year-over-year growth. The miss may raise concerns about the company's ability to meet expectations, which can lead to a decrease in stock price.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100